October 30,2007
Grassley delves further into FDA review of foreign-made pharmaceuticals
WASHINGTON — Sen. Chuck Grassley is following up on his initial inquiry of the Food and Drug Administration regarding its work to ensure the safety of foreign-made pharmaceutical ingredients and medicines with a series of questions about foreign inspection funding, FDA registration of foreign plants, newly emerging exporters of pharmaceuticals, and weaknesses in the foreign inspection process.
The text of the letter he sent today to the FDA Commissioner follows here, along with the text of his August letter.
###
Next Article Previous Article
Recent News
- Wyden Statement on Republican Tax Plans and Cuts to Medicaid and Food Assistance
- Wyden Statement on Trump CMS Administrator Announcement
- Wyden Statement on Trump HHS Secretary Nomination Announcement
- Wyden Hearing Statement on TIGTA Nomination
- Democratic Health Leaders Warn Medicare Advantage is Falling Short for Seniors, Americans with Disabilities